Differences in rates of bDMARD treatment initiation among US veterans with RA living in rural vs urban areas cannot be fully explained by location.

Thyroid hormone resistance is associated with chronic constipation, according to study findings published in the Journal of Clinical Gastroenterology. Hypothyroidism has been associated with ...

Costs related to cardiovascular health care represent a high burden and have been trending upward the past several years in the United States.

Primary ovarian insufficiency was associated with a higher risk for autoimmune conditions including hypothyroidism and adrenal insufficiency.

Cesarean delivery-related obstetric factors may increase the risk for postpartum depression, including severe postoperative pain and bad memories of the delivery.

Fast subjective walking speed is associated with lower odds of metabolic diseases among individuals with obesity.

Childhood diabetes incidence had increased since 1990, mortality and DALYs had decreased, and cases were projected to decrease.

Health care spending in the United States reached $4.9 trillion and increased 7.5% in 2023, according to a study.

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

The FDA has issued a CRL to Lexicon regarding the NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for T1D and CKD.

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

Results from the VENTURE trial showed significant reductions in weight and hunger among younger patients treated with setmelanotide.